Intra-operative Radiation Therapy - IORT

RADIATION3 trials

Sponsors

Xoft, Inc., Parkridge Medical Center

Conditions

Ductal Carcinoma In SituDuctal Carcinoma in SituGBMGlioblastomaInvasive Ductal CarcinomaRecurrent GBM

Unknown Phase

Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®

Active, not recruitingNCT01644669

Xoft, Inc.Ductal Carcinoma in Situ, Invasive Ductal Carcinoma

Start: 2012-05-08End: 2029-12-31Updated: 2025-01-31

An Efficacy Study of the Xoft® Axxent® eBx® IORT System® Lite

WithdrawnNCT04349111

Xoft, Inc.Ductal Carcinoma In Situ, Invasive Ductal Carcinoma

Start: 2022-06-30End: 2034-06-30Updated: 2022-08-02

Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT

TerminatedNCT04763031

Parkridge Medical CenterGBM, Glioblastoma, Recurrent GBM

Start: 2021-03-05End: 2023-11-03Updated: 2023-11-09

Related Papers

Abstract P1-10-19: Two-year follow-up results of a multi-center trial of intra-operative electronic brachytherapy during breast conservation surgery for early stage breast cancer

Cancer Research2017-02-15

Abstract P1-10-20: A multi-center trial of intra-operative electronic brachytherapy during breast conservation surgery for early stage breast cancer: Early results of unplanned boost participants

Cancer Research2017-02-15